Women with pain due to osteoarthritis: The efficacy and safety of a once-daily formulation of tramadol

Pain Medicine

Volumn 10, Issue 6, 2009, Pages 1001-1011

  Kean, Walter F ^a   Bouchard, Sylvie ^b   Roderich Gossen, E ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b Lakeshore General Hospital   (Canada)

^c Labopharm Inc   (Canada)

Author keywords

Analgesia; Controlled release; Osteoarthritis; Pain; Tramadol; Women

Indexed keywords

PLACEBO; TRAMADOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIZZINESS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PHYSICAL CAPACITY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; SWEATING; VOMITING; WOMEN'S HEALTH; XEROSTOMIA;

ADULT; AGED; ANALGESICS, OPIOID; BODY MASS INDEX; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; HUMANS; MIDDLE AGED; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PATIENT COMPLIANCE; TRAMADOL;

EID: 70349513100     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00677.x     Document Type: Article

References (44)

1. Greenspan JD, Craft RM, LeResche L, et al. Studying sex and gender differences in pain and analgesia: A consensus report. Pain 2007, 132(1):S26-45. ., suppl
2. Srikanth VK, Fryer JL, Zhai G, et al. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage 2005, 13:769-781. .
3. O'Connor MI. Sex differences in osteoarthritis of the hip and knee. J Am Acad Orthop Surg 2007, 15(1):S22-5. suppl
4. Rosemann T, Laux G, Szecsenyi J. Osteoarthritis: Quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients. J Orthop Surg Res 2007, 2:12.
5. Pahor M, Guralnik JM, Wan JY, et al. Lower body osteoarticular pain and dose of analgesic medications in older disabled women: The Women's Health and Aging Study. Am J Public Health 1999, 89:930-934. .
6. Tannenbaum H, Bombardier C, Davis P, Russell AS. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference. J Rheumatol 2006, 33:140-157.
7. Kean WF, Buchanan WW. The use of NSAIDs in rheumatic disorders 2005: A global perspective. Inflammopharmacology 2005, 13:343-370.
8. Schug SA. The role of tramadol in current treatment strategies for musculoskeletal pain. Ther Clin Risk Manag 2007, 3:717-723.
9. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16:137-162. .
10. Trubetskoy VS. Polymeric micelles as carriers of diagnostic agents. Adv Drug Deliv Rev 1999, 37:81-88.
11. Prescribing Guidelines for Primary Care Clinicians, Low Back Pain: Rational Use of Opioids in Chronic or Recurrent Non-Malignant Pain 2002, New South Wales Therapeutic Assessment Group, Darlinghurst, New South Wales, Australia, NSW Therapeutic Assessment Group
12. van Tulder MW, Koes B, Bombardier C. Low back pain. Best Pract Res Clin Rheumatol 2002, 16:761-775.
13. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007, 147:478-491. .
14. Airaksinen O, Brox JI, Cedraschi C, et al. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006, 15(2):S192-300. ., suppl
15. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007, 132:237-251. .
16. Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain-Consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007, 12:13-21. .
17. Francesca F, Bader P, Echtle D, Giunta F, Williams J. Guidelines on Pain Management 2007, 1-58. Arnhem, The Netherlands, European Association of Urology (EAU)
18. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000, 43:1905-1915. American College of Rheumatology
19. Kean WF, Rainsford KD, Kean IR. Management of chronic musculoskeletal pain in the elderly: Opinions on oral medication use. Inflammopharmacology 2008, 16:53-75.
20. Cepeda MS, Camargo F, Zea C, Valencia L. Tramadol for osteoarthritis: A systematic review and metaanalysis. J Rheumatol 2007, 34:543-555.
21. Mongin G, Yakusevich V, Köpe A, et al. Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: A randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee. Clin Drug Investig 2004, 24:545-558. .
22. Burch F, Fishman R, Messina N, et al. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage 2007, 34:328-339. .
23. Fishman RL, Kistler CJ, Ellerbusch MT, et al. Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD). J Opioid Manag 2007, 3:273-280. .
24. Mattia C, Coluzzi F. Once-daily tramadol in rheumatological pain. Expert Opin Pharmacother 2006, 7:1811-1823.
25. Mongin G. Tramadol extended-release formulations in the management of pain due to osteoarthritis. Expert Rev Neurother 2007, 7:1775-1784.
26. Karhu D, El-Jammal A, Dupain T, Gaulin D, Bouchard S. Pharmacokinetics and dose proportionality of three Tramadol Contramid® OAD tablet strengths. Biopharm Drug Dispos 2007, 28:323-330.
27. Hernandez-Lopez C, Martinez-Farnos L, Karhu D. et al. Comparative bioavailability between two tramadol once-daily oral formulations. Methods Find Exp Clin Pharmacol 2006, 28:373-378. .
28. Manek NJ, Lane NE. Osteoarthritis: Current concepts in diagnosis and management. Am Fam Physician 2000, 61:1795-1804.
29. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 15:1833-1840.
30. McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): A review of its utility and measurement properties. Arthritis Rheum 2001, 45:453-461.
31. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: What is moderate pain in millimetres?. Pain 1997, 72:95-97.
32. Fillingim RB, Gear RW. Sex differences in opioid analgesia: Clinical and experimental findings. Eur J Pain 2004, 8:413-425.
33. Rollman GB, Abdel-Shaheed J, Gillespie JM, Jones KS. Does past pain influence current pain: Biological and psychosocial models of sex differences. Eur J Pain 2004, 8:427-433.
34. Brandt KD. Osteoarthritis. Harrison's Principles of Internal Medicine 1994, 1692-1698. London, New York, McGraw-Hill
35. Pavelka K. Treatment of pain in osteoarthritis. Eur J Pain 2000, 4(A):23-30. suppl
36. Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007, 15:957-965.
37. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008, 11:S105-20. .
38. Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008, 11:S5-62. .
39. Kayser V, Besson J-M, Guilbaud G. Effects of the analgesic agent tramadol in normal and arthritic rats: Comparison with the effects of different opioids, including tolerance and cross-tolerance to morphine. Eur J Pharmacol 1991, 195:37-45.
40. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am 2007, 91:199-211.
41. Houlihan DJ. Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. Ann Pharmacother 2004, 38:411-413.
42. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007, 15:981-1000. .
43. Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs. An update for clinicians. A scientific statement from the American Heart Association. Circulation 2007, 115:1634-1642. .
44. McCarberg B. Tramadol extended-release in the management of chronic pain. Ther Clin Risk Manag 2007, 3:401-410.